Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

Share Price Information for De La Rue (DLAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 96.20
Bid: 93.60
Ask: 96.20
Change: 2.80 (3.00%)
Spread: 2.60 (2.778%)
Open: 93.40
High: 96.20
Low: 93.40
Prev. Close: 96.20
DLAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rejection Announcement

6 Dec 2010 17:12

RNS Number : 4638X
De La Rue PLC
06 December 2010
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

6 December 2010

 

 

 

 

REJECTION OF OPPORTUNISTIC APPROACH BY OBERTHUR

 

 

De La Rue plc ("De La Rue" or the "Company" DLAR:L) notes today's announcement by Francois-Charles Oberthur Fiduciaire S. A. ("Oberthur") and confirms that it received a highly preliminary indicative proposal for the Company from Oberthur at 905p a share. The Board of De La Rue (the "Board"), having discussed the approach with its advisers, believes the proposal in no way reflects the fundamental value of the Company. Consequently the Board was unanimous in rejecting this opportunistic approach.

 

De La Rue is a unique business based on strong fundamentals and its long-term value should not reflect the current issues which management is addressing:

 

n De La Rue's core markets have shown steady growth, and the business has significant barriers to entry

n De La Rue is a global brand, built up over nearly 200 years, with strong customer relationships

n De La Rue has an experienced and highly skilled workforce

n De La Rue has been successful in developing its traditional strengths, most recently winning, and delivering on time, the complex £400 million ten year UK passport contract

n De La Rue's strong balance sheet supports continued investment in design capability and technical innovation

n De La Rue's operations are highly cash generative

 

Commenting on the approach, Nicholas Brookes, Chairman of De La Rue, said:

 

"De La Rue is a unique company and has world leading positions in growth markets with high barriers to entry. We are addressing the current issues, which should not detract from the attractive medium and long-term prospects for the Company. The Board had no hesitation in rejecting this highly opportunistic and preliminary proposal which does not begin to reflect De La Rue's fundamental value."

 

This announcement has not been made with the consent of Oberthur and there can be no certainty that an offer will be forthcoming.

 

A copy of this announcement will be available at www.delarue.com

 

The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

Enquiries

 

Jon Coles and Kate Holgate, Brunswick Group - 0207 404 5959

 

Disclosure requirements of the City Code on Takeovers and Mergers (the "Code")

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of

relevant securities of an offeree company or of any paper offeror (being any offeror other than

an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in

cash) must make an Opening Position Disclosure following the commencement of the offer

period and, if later, following the announcement in which any paper offeror is first identified.

An Opening Position Disclosure must contain details of the person's interests and short

positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree

company and (ii) any paper offeror(s). An Opening Position Disclosure by a person to whom

Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th

business day following the commencement of the offer period and, if appropriate, by no later

than 3.30 pm (London time) on the 10th business day following the announcement in which

any paper offeror is first identified. Relevant persons who deal in the relevant securities of the

offeree company or of a paper offeror prior to the deadline for making an Opening Position

Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of

any class of relevant securities of the offeree company or of any paper offeror must make a

Dealing Disclosure if the person deals in any relevant securities of the offeree company or of

any paper offeror. A Dealing Disclosure must contain details of the dealing concerned and of

the person's interests and short positions in, and rights to subscribe for, any relevant

securities of each of (i) the offeree company and (ii) any paper offeror, save to the extent that

these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person

to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the

business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether

formal or informal, to acquire or control an interest in relevant securities of an offeree

company or a paper offeror, they will be deemed to be a single person for the purpose of Rule

8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror

and Dealing Disclosures must also be made by the offeree company, by any offeror and by

any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening

Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure

Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of

the number of relevant securities in issue, when the offer period commenced and when any

offeror was first identified. If you are in any doubt as to whether you are required to make an

Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel's Market

Surveillance Unit on +44 (0)20 7638 0129.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OTTDQLFBBLFBFBK
Date   Source Headline
30th May 20247:00 amRNSStrategic Update
2nd May 202411:39 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSPre-Close Trading Statement
16th Apr 202411:52 amRNSHolding(s) in Company
16th Apr 202410:59 amRNSHolding(s) in Company
3rd Apr 20247:00 amRNSExtension of contract with Microsoft
2nd Apr 202411:25 amRNSTotal Voting Rights
7th Mar 20241:04 pmRNS2023 AGM Voting Update
23rd Feb 20242:06 pmRNSAdditional Listing
29th Jan 20244:14 pmRNSHolding(s) in Company
26th Jan 20244:38 pmRNSDirector/PDMR Shareholding
18th Jan 20243:19 pmRNSHolding(s) in Company
18th Jan 202412:13 pmRNSHolding(s) in Company
2nd Jan 202411:33 amRNSBlock listing Interim Review
21st Dec 20233:51 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNS2023/24 half year results
27th Nov 20232:53 pmRNSHolding(s) in Company
1st Nov 20231:51 pmRNSTotal Voting Rights
30th Oct 202311:05 amRNSHolding(s) in Company
13th Oct 202310:27 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSPre-close Trading Statement
2nd Oct 202311:47 amRNSTotal Voting Rights
20th Sep 202312:59 pmRNSDirector/PDMR Shareholding
13th Sep 20231:09 pmRNSHolding(s) in Company
7th Sep 20231:59 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM statement and trading update
4th Sep 202312:36 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
14th Aug 20233:30 pmRNSHolding(s) in Company
11th Aug 20232:58 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.